Actionable intelligence enhances situational awareness for global healthcare security professionals.

LighthouseAI applies artificial intelligence to life sciences compliance

New funding led by ICONIQ Growth brings total raised to $207 million and signals investor confidence in Apprentice's market-leading technology

According to Statista, China has the second largest pharmaceutical market in the world and plant-based medicines are very well accepted, which makes China a potential target market for Gb Sciences.

AmplifyBio builds on the T-cell immunology expertise of its South San Francisco-based team, adding technology platforms and capabilities in single-cell analysis and product assessment in the context of a tumor microenvironment.

New multiyear collaboration between Florence Healthcare and IQVIA to ensure research sites participating in IQVIA studies have access to best-in-class site enablement technology to streamline operations and power remote connectivity.

Senior executive brings deep financial planning and analysis experience to leadership team.

The new website is part of Broad Institute's mission to support innovation and breakthroughs in the science and research community.

Following Record Sales Growth and Launch of Disruptive New Product

Interactome Bio Expands to Chicago's Portal Innovations

NTM-001 is an Investigational, Alcohol-Free, Stable Formulation of Ketorolac in a Pre-Mixed Bag for 24h Continuous Infusion. NTM-001 has the Potential to Deliver Opioid-Level Pain Relief Without Analgesic Gaps and Reduce or Eliminate the Need for Opioids. Phase 3 Efficacy and Safety Study is Comparing NTM-001 vs. Placebo, and Includes a Morphine Arm for Assay Sensitivity in Patients with Moderately Severe Pain After Bunionectomy Surgery. Results Expected Second Half 2023.

Panoramic Health Triples Number of Medicare Patients Under Care Across 18 KCEs in 14 States During Tremendous Growth Year

URAC recognizes OptiMed Health Partners' impressive work in Specialty Pharmacy.

Potential lead-in trial to drug trial of novel enzyme replacement therapy

Refreshed logo and branding exemplifies the success and mission of Health-ISAC

Aronora co-founder and CEO Dr. Erik Tucker has been elected as Fellow of the National Academy of Inventors (NAI)

Joe Urban, Potrero's Chief Executive Officer, is scheduled to present at Jefferies Virtual Private MedTech Summit

Presentation to include clinical data from a phase 2 study of Gruticibart (AB023), a factor XI-targeted antibody being developed for the treatment and prevention of thrombosis and inflammation